Sarissa Capital Management as of Sept. 30, 2021
Portfolio Holdings for Sarissa Capital Management
Sarissa Capital Management holds 10 positions in its portfolio as reported in the September 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alkermes SHS (ALKS) | 32.0 | $408M | 13M | 30.84 | |
| Ironwood Pharmaceuticals Com Cl A (IRWD) | 16.8 | $214M | 16M | 13.06 | |
| Gilead Sciences (GILD) | 16.3 | $207M | 3.0M | 69.85 | |
| Biogen Idec (BIIB) | 14.3 | $182M | 643k | 282.99 | |
| Innoviva (INVA) | 8.7 | $111M | 6.6M | 16.71 | |
| BioCryst Pharmaceuticals (BCRX) | 4.4 | $56M | 3.9M | 14.37 | |
| Amarin Corp Spons Adr New (AMRN) | 3.4 | $43M | 8.5M | 5.10 | |
| Mersana Therapeutics (MRSN) | 3.2 | $41M | 4.3M | 9.43 | |
| Vor Biopharma (VOR) | 0.9 | $11M | 707k | 15.68 | |
| Regulus Therapeutics Com New | 0.1 | $1.3M | 1.9M | 0.69 |
